Dianthus Therapeutics DNTH Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dianthus Therapeutics's increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dianthus Therapeutics's increase (decrease) in other operating assets?
- Dianthus Therapeutics (DNTH) reported increase (decrease) in other operating assets of $2.12M in Q1 2026.
- How has Dianthus Therapeutics's increase (decrease) in other operating assets changed year-over-year?
- Dianthus Therapeutics's increase (decrease) in other operating assets increased by 206.2% year-over-year, from -$2M to $2.12M.
- What is the long-term trend for Dianthus Therapeutics's increase (decrease) in other operating assets?
- Over 2 years (2022 to 2024), Dianthus Therapeutics's increase (decrease) in other operating assets has grown at a 1522.7% compound annual growth rate (CAGR), from $31K to $8.16M.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.